Drugs and medicines

The RCPCH and IQVIA have jointly developed a new one-year placement programme for paediatric trainees. Applications for the 2019-20 placement are now open until 11 February.

The aim of this evidence-based statement is to summarise the current knowledge about delayed prescriptions (also called backup prescriptions) for antibiotics and to highlight the special issues that must be taken into account when considering the need for a delayed prescription in infants and childr...

A new feature for our 2019 RCPCH Conference and exhibition, these talks will showcase the latest ideas and discoveries in child health.

RCPCH responds to new research which suggests these drugs may alter gut microbes associated with weight gain.

The following case study from Calderdale and Huddersfield NHS Foundation Trust was included in the 2018 annual report on 2017 data, and highlights how NNAP results can be used as a basis for identifying, and undertaking, local quality improvement activities.

The Department of Health & Social Care has issued urgent guidance relating to supply disruption of Mylan EpiPens for all health care professionals who prescribe, dispense or administer adrenaline auto-injectors.

This case study from Watford General Hospital, West Hertfordshire NHS Trust was included in the 2018 annual report on 2017 data, and highlights how some neonatal units have used NNAP results as a basis for identifying, and undertaking, local quality improvement activities.

Our medicines information resource for parents and children is shortlisted for the “Optimisation of Medicines Management” category of the Health Service Journal Award, which celebrates healthcare excellence.

The Royal College of Paediatrics and Child Health and British Paediatric Neurology Association has developed this Q&A in light of recent developments in this area. It advises on the legality and safety of cannabis-based products and considers the evidence base for their potential harms and benefits.

RCPCH Registrar, Dr Mike Linney, says the decision will 'come as a relief for some'. He warns parents in the meantime to not give children unlicensed cannabinoid oil products.